WHO/Q. Mattingly
                                ? Credits

                                Antimicrobial resistance

                                  Overview

                                  Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

                                  AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.

                                  Antimicrobials - including antibiotics, antivirals, antifungals and antiparasitics - are medicines used to prevent and treat infections in humans, animals and plants. Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.

                                  Global AMR response

                                  WHO's core mandate

                                  is to coordinate the global response in collaboration with key partners

                                  Addressing SDGs

                                  Mitigating AMR will have a huge impact on reaching 6 of the 17 sustainable development goals (SDGs)

                                  AMR & SDGs

                                  1.2 trillion USD

                                  additional health expenditure per year expected by 2050 due to the rise of antimicrobial resistance.

                                  "Together with our partners, we’re also stepping up the fight against antimicrobial resistance, one of the most urgent health threats of our time."

                                  Dr. Tedros Adhanom Ghebreyesus, WHO Director-General

                                  Publications

                                  All →
                                  Antimicrobial resistance and the United Nations sustainable development cooperation framework: guidance for United Nations country teams

                                  The United Nations Sustainable Development Cooperation Framework (“Cooperation Framework”) is an agreement between the UN and the host government...

                                  WHO Costing and Budgeting Tool for National Action Plans on Antimicrobial Resistance

                                  In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for...

                                  The AWaRe Classification of antibiotics was developed in 2017 by the WHO Expert Committee on Selection and Use of Essential Medicines as a tool to support...

                                  Executive summary: the selection and use of essential medicines 2021: report of the 23rd WHO Expert Committee on the selection and use of essential medicines

                                   This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines...

                                  Newsletter

                                  Welcome to WHO Antimicrobial Resistance Newsletter Spring 2021

                                  Our quarterly newsletter will bring you updates on progress by countries, and activities taking place at all three levels of the organization with the support of our partners and donors. Learn about important publications, projects, events and high-level fora taking place around the world on AMR, as well as the implications for the COVID-19 pandemic for AMR.

                                  Access the newsletter:

                                  January 2021 →

                                  May 2021 →

                                  September 2021 →

                                  December 2021 →